Publication
Science
Vol 215, Issue 4529, pp. 190-192
Abstract
Sympathetic nervous system activity was assessed in experimental and control subjects who were exposed to graded orthostatic and isometric stress during monthly hospital visits. After the first session, the experimental subjects practiced a technique that elicited the relaxation response. Their concentrations of plasma norepinephrine during subsequent graded stresses were significantly higher. No such changes were noted in the control group. These results were then replicated in the control group in a crossover experiment. The groups did not differ in their heart rate and blood pressure responses. These observations are consistent with reduced norepinephrine end-organ responsivity after regular elicitation of the relaxation response.
Web and Email Links
Related Listings
Journal
Journal of Cardiovascular Nursing
Hypertension is one of the leading health problems in the United States. It is commonly accepted that as many as 60 million Americans have hypertension, with the majority (>70%) having mild elevations (diastolic pressure range, 90-104 mm Hg). The treatment of hypertension accounts for more office visits to health care providers and more treatment than any other medical diagnosis. A 1980 National Institutes of Health survey showed that about 2% of visits to health care providers wer […]
Journal
Behavioral Medicine
This randomized, prospective study investigated the effectiveness of two group behavioral medicine interventions for primary care patients experiencing physical symptoms with a psychosocial component (eg, palpitations, gastrointestinal disturbances, headaches, malaise, sleep disorders). The subjects were 80 volunteers at a health maintenance organization (HMO) in the greater Boston area. Both interventions focused on the mind/body relationship and used didactic material, relaxation-re […]
Journal
Journal Alternative and Complementary Medicine
Objective: Mind–body practices that elicit the relaxation response (RR) have been demonstrated to reduce blood pressure (BP) in essential hypertension (HTN) and may be an adjunct to antihypertensive drug therapy. However, the molecular mechanisms by which the RR reduces BP remain undefined. Design: Genomic determinants associated with responsiveness to an 8-week RR-based mind–body intervention for lowering HTN in 13 stage 1 hypertensive patients classified as BP responders and 11 as n […]